Joseph Sullivan
Neurology with Special Qualifications in Child Neurology · San Francisco, CANPI 1952321135
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $200,180 of the $240,138 with a category attached, or 83.4%. 19 manufacturers reported payments, led by Ceribell, Inc. at 40.1% of the total. 2025 is the largest year on record at $111,729, more than ten times the $4,895 reported in 2019. Among neurology with special qualifications in child neurology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 118 payments — averaging $2035.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ceribell, Inc.$96K
- Biocodex, Inc.$54K
- UCB SA$26K
- UCB, Inc.$23K
- Jazz Pharmaceuticals Inc.$13K
- Greenwich Biosciences, Inc.$10K
- plus $18K from 13 others
Across 77 payments — averaging $19,049 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Takeda Pharmaceuticals U.S.A., Inc.$926K
- Zogenix Inc.$387K
- UCB SA$95K
- Immedica Pharma US, Inc.$30K
- H. Lundbeck A S$29K
What the payments were for
- Consulting fees$200,18083%
- Speaking & faculty fees$10,8054%
- Travel & lodging$25,44311%
- Food & beverage$3,6972%
- Education$130%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ceribell, Inc. | 20 | $96,200 |
| Biocodex, Inc. | 24 | $53,916 |
| UCB SA | 8 | $26,238 |
| UCB, Inc. | 23 | $23,329 |
| Jazz Pharmaceuticals Inc. | 9 | $13,048 |
| Greenwich Biosciences, Inc. | 6 | $9,672 |
| Zogenix Inc. | 3 | $4,710 |
| BTG International Inc. | 4 | $2,903 |
| Biogen | 1 | $2,500 |
| Immedica Pharma US, Inc. | 5 | $1,963 |
| Eisai Inc. | 1 | $1,680 |
| Biomarin Pharmaceutical Inc. | 1 | $1,600 |
| Medtronic | 1 | $550 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $480 |
| SK Life Science, Inc. | 3 | $450 |
| Sunovion Pharmaceuticals Inc. | 4 | $404 |
| Aquestive Therapeutics, Inc. | 1 | $255 |
| Livanova USA, Inc. | 2 | $228 |
| Neurelis, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- POCKET EEG DEVICE$82,440
- DIACOMIT$53,626
- Fintepla$36,390
- Ceribell Rapid Response EEG$13,760
- Epidiolex$13,737
- Fycompa$1,680
- Brineura$1,600
- ZTALMY$602
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR$228
- LONHALA MAGNAIR$108
How this compares
$240,138 in reported general payments places this provider in the 95th percentile of 216 neurology with special qualifications in child neurology providers in California.
See all neurology with special qualifications in child neurology providers in California →
Other neurology with special qualifications in child neurology in San Francisco
- Akash VirupakshaiahSan Francisco$94K
- Nilika SinghalSan Francisco$27K
- Sabine MuellerSan Francisco$11K
- Michael ChezSacramento$374K
- Allen BottOakland$372K
- Ann SegerenStanford$172K
- Rajsekar RajaramanLos Angeles$134K
- Deborah HolderLos Angeles$130K
- Brittany PassiakSan Diego$90K
- Kevin ShapiroMadera$84K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.